Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial).
Miguel SantinSandra Perez-RecioMaria D GrijotaLuis Anibarro-GarcíaJose M BarcalaMaria L De Souza-GalvaoPaloma GijonRafael LuqueFrancesca Sancheznull nullPublished in: PloS one (2022)
ClinicalTrials.gov identifier: NCT05021731.